LAVOIEHEALTHSCIENCE Etrasimod 2 mg treatment group achieved statistical significance in the percentage change in weekly peak pruritis (PP-NRS), in the change in Dermatology Life Quality Index (DLQI), and in the change in Patient-Oriented Eczema Measure (POEM) Etrasimod 2 mg was generally well tolerated, consistent with data in previous trials Park City, Utah, April 23, 2021...